Jaggar J H, Harding E A, Ayton B J, Dunne M J
Department of Biomedical Science, University of Sheffield, UK.
J Mol Endocrinol. 1993 Feb;10(1):59-70. doi: 10.1677/jme.0.0100059.
The hyperglycaemia-inducing sulphonamide diazoxide has been previously shown to mediate its effects upon insulin secretion by opening K+ channels and hyperpolarizing the beta-cell membrane. The target site has been characterized as the ATP-regulated K+ (K+ATP) channel protein. In the present study, a detailed investigation of interactions of diazoxide and another K+ channel opener, cromakalim, with K+ATP channels has been performed in individual insulin-secreting cells using patch-clamp techniques. In agreement with previous studies, diazoxide and cromakalim were found to be effective only when ATP was present upon the inside face of the plasma membrane. The ability of both diazoxide and cromakalim to open channels was, however, found to diminish with time following isolation of inside-out patches. Within seconds of forming the recording configuration, the actions of both compounds were potent, and were found to decline steadily as the number of operational channels decreased ('run-down'). In open cells, where the plasma membrane remains partially intact, the rate of run-down was significantly reduced, and effects of channel openers were recorded up to 80 min following cell permeabilization. We also demonstrated that in the absence of ATP, but in the presence of ADP, both diazoxide and cromakalim were able to open K+ATP channels. Interestingly, once the effects of diazoxide and cromakalim on K+ATP channels in the presence of ATP were lost, both compounds opened channels in the presence of ADP. One implication of these data is that the actions of diazoxide and cromakalim involve regulatory proteins associated with the ion channel; this molecule is able to bind ATP, ADP and possibly other cytosolic nucleotides.
先前已表明,可诱导高血糖的磺酰胺类药物二氮嗪通过开放钾通道并使β细胞膜超极化来介导其对胰岛素分泌的作用。其作用靶点已被确定为ATP调节钾通道(K⁺ATP)蛋白。在本研究中,利用膜片钳技术在单个胰岛素分泌细胞中对二氮嗪和另一种钾通道开放剂克罗卡林与K⁺ATP通道的相互作用进行了详细研究。与先前的研究一致,发现二氮嗪和克罗卡林仅在质膜内侧存在ATP时才有效。然而,发现二氮嗪和克罗卡林开放通道的能力在分离内向外膜片后会随时间减弱。在形成记录构型后的几秒钟内,这两种化合物的作用都很强,并且随着可操作通道数量的减少(“衰减”)而稳步下降。在细胞膜仍部分完整的开放细胞中,衰减速率显著降低,并且在细胞透化后长达80分钟都能记录到通道开放剂的作用。我们还证明,在没有ATP但存在ADP的情况下,二氮嗪和克罗卡林都能够开放K⁺ATP通道。有趣的是,一旦二氮嗪和克罗卡林在存在ATP时对K⁺ATP通道的作用消失,这两种化合物在存在ADP时都能开放通道。这些数据的一个含义是,二氮嗪和克罗卡林的作用涉及与离子通道相关的调节蛋白;该分子能够结合ATP、ADP以及可能的其他胞质核苷酸。